In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
D000900:Anti-Bacterial Agents / Q000633:toxicity* / Q000652:urine; D001419:Bacteria / Q000187:drug effects*; D002937:Cinoxacin / Q000633:toxicity*; D004754:Enterobacter / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000633:toxicity*; D009539:Nicotinic Acids / Q000633:toxicity*; D009643:Norfloxacin; D010876:Pipemidic Acid / Q000633:toxicity*; D011724:Pyridazines / Q000633:toxicity*; D012706:Serratia marcescens / Q000187:drug effects
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D011724:Pyridazines; D009268:Nalidixic Acid; D002937:Cinoxacin; D010876:Pipemidic Acid; D009643:Norfloxacin